Table 3.
Correlates of COVID-19 vaccine hesitancy among HIV-infected MSM in China
| Variables | aOR (95% CI) | P |
|---|---|---|
| Age, year | ||
| ≤25 | 0.71 (0.34–1.47) | 0.359 |
| 26–44 | 0.91 (0.45–1.84) | 0.799 |
| ≥45 | Ref | |
| Level of depression severity, PHQ-9 score | ||
| Minimal (scores 0–4) | Ref | |
| Mild (scores 5–9) | 0.99 (0.66–1.47) | 0.947 |
| Moderate (scores 10–14) | 1.29 (0.78–2.13) | 0.321 |
| Moderately severe (scores 15–19) | 1.19 (0.62–2.29) | 0.597 |
| Severe (scores 20–27) | 1.07 (0.50–2.31) | 0.854 |
| Level of anxiety severity, GAD-7 score | ||
| Minimal (scores 0–4) | Ref | |
| Mild (scores 5–9) | 1.25 (0.85–1.85) | 0.264 |
| Moderate (scores 10–14) | 1.02 (0.59–1.78) | 0.944 |
| Severe (scores 15–21) | 0.90 (0.44–1.81) | 0.760 |
| HIV transmission route | ||
| Male-male sex | Ref | |
| Other | 2.10 (0.93–4.73) | 0.072 |
| Not sure | 1.39 (0.83–2.33) | 0.210 |
| ART adherence, MMAS-8 score | ||
| Low (scores < 6) | Ref | |
| Medium (6 ≤ scores < 8) | 0.91 (0.63–1.33) | 0.635 |
| High (scores = 8) | 0.53 (0.35–0.80) | 0.003 |
| Perception of the severity of SARS-CoV-2 | ||
| Severe | 0.65 (0.34–1.24) | 0.192 |
| Moderate | 0.78 (0.41–1.49) | 0.451 |
| Mild | 1.56 (0.66–3.65) | 0.311 |
| No idea | Ref | |
| Frequency of following information about the COVID-19 vaccine | ||
| Often | 0.26 (0.17–0.40) | <0.001 |
| Sometimes | 0.46 (0.31–0.67) | <0.001 |
| Seldom or never | Ref | |
| Vaccine preference | ||
| Domestic vaccines | 0.37 (0.24–0.59) | <0.001 |
| Imported vaccines | Ref | |
| Can ART prevent COVID-19 | ||
| Yes | Ref | |
| No | 0.97 (0.65–1.45) | 0.891 |
| Not sure | 1.37 (0.93–2.00) | 0.110 |
| COVID-19 impact on immunity | ||
| Moderately severe or severe | 0.54 (0.38–0.78) | 0.001 |
| Moderate | 0.58 (0.38–0.90) | 0.014 |
| Mild or none | Ref | |
| Reasons not to initiate the COVID-19 vaccination | ||
| Concern about the efficacy | ||
| Yes | 1.72 (1.16–2.54) | 0.007 |
| No | Ref | |
| Concern about side effects | ||
| Yes | 2.44 (1.78–3.35) | <0.001 |
| No | Ref | |
| Concern about disclosure of HIV infection | ||
| Yes | 1.06 (0.78–1.43) | 0.707 |
| No | Ref | |
| Waiting for vaccination programs organized at workplace | ||
| Yes | 0.60 (0.44–0.81) | 0.001 |
| No | Ref | |
| Did not know where to where to get COVID-19 vaccine | ||
| Yes | 0.61 (0.45–0.82) | 0.001 |
| No | Ref |
The bold values are statistically significant (P < .05). aOR, adjusted odds ratio; CI, confidence interval; MSM, men who have sex with men; ART, antiretroviral therapy.